Overview

Fracture Recovery for Returning to Duty (Teriparatide STRONG)

Status:
Not yet recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
The project goals are to improve combat readiness of U.S. Soldiers and sustain the availability of the military to deploy by, 1) decreasing the number of days not physically ready for duty after diagnosis of a diaphyseal tibial stress fracture, 2) decreasing the need for a physical profile or medical discharge board after bone stress injury, and 3) decreasing the recurrence rates of bone stress injuries.
Phase:
Phase 4
Details
Lead Sponsor:
Prisma Health-Midlands
University of South Carolina
Collaborators:
Eisenhower Army Medical Center
Moncrief Army Health Clinic
United States Department of Defense
University of South Carolina
Treatments:
Teriparatide